Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).
Share price

Latest presentations

Analyst reports

Investment themes

Latest CEO Comments

APRIL 28, 2022
"Promising start to 2022"
Read the latest CEO comments from Nikolaj Sørensen
News flow
Press Releases and News
One Pill Can Kill – Fentanyl Awareness Day May 10
Orexo´s partner Gesynta Pharma granted Orphan Drug Designation by the FDA for OX-MPI (GS-248) for the treatment of systemic sclerosis
Orexo appoints Fredrik Järrsten as new CFO
Orexo's lead product ZUBSOLV® added to NY State Medicaid MAT Preferred Drug List
Key financial figures
Group net revenue
Group EBITDA
US Pharma segment EBIT
Cash position
